Clinical Trial Update: LC-Plasma for Preventing URTIs and Reducing Symptoms [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating LC-Plasma for preventing upper respiratory tract infections and reducing symptoms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Respiratory Tract Infection

Drugs mentioned

• LC-Plasma

Snippet

Sponsor: RDC Clinical Pty Ltd | Conditions: Healthy Volunteer, URTI | Phase 3 | Status: COMPLETED